Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$19.72 - $28.68 $887 - $1,290
-45 Reduced 47.87%
49 $1,000
Q3 2023

Oct 30, 2023

SELL
$22.33 - $29.92 $1,406 - $1,884
-63 Reduced 40.13%
94 $2,000
Q2 2023

Aug 03, 2023

BUY
$20.96 - $26.99 $3,290 - $4,237
157 New
157 $4,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Psagot Value Holdings Ltd. Portfolio

Follow Psagot Value Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

News

Stay updated on Psagot Value Holdings Ltd. with notifications on news.